For patients with depression due to the use of analgesics, whether or not the analgesics they use act on ERK/CREB pathway, they can use some drugs appropriately after the pain symptoms are relieved to activate the ERK/CREB pathway and relieve the depressive symptoms. This evidence concerns the gene MAPK1 and depressive disorder.